Skip to main content

Weather Alert

Hurricane activity is severely impacting Quest locations across the Southeast. We ask that patients please double check your appointment status to ensure your designated Patient Service Center is operational.

Hide
Quest Diagnostics

Optimizing Identification of Allergic Sensitization to Seasonal Inhalant Allergens in the USA: Implications for Constructing Optimal Panels to Evaluate Patients with Allergy

Optimizing Identification of Allergic Sensitization to Seasonal Inhalant Allergens in the USA: Implications for Constructing Optimal Panels to Evaluate Patients with Allergy

Authors: Kwong KY, Chen Z, Scott L, Hilborne LH

Citation: Int Arch Allergy Immunol. 2024 May 23:1-8. doi: 10.1159/000538420. Online ahead of print.

Specialties: Infectious disease, Allergy, Immunology

Download key summary

Related content

Conference Presentation
Allergic Sensitization to Inhalant Allergens in the United States
Conference Presentation
Optimal Identification of Allergic Sensitization Toward Seasonal Inhalant Allergens in the United States
On-Demand Webinar
Interpretation of Respiratory Allergy Results for Patient Management

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.